Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

ResearchDx, the leading Contract Diagnostics Organization, expands operations into the Middle East


Print article Print article
© Business Wire 2014
2014-01-27 03:01:01 -

ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets.

As part of this initiative, ResearchDx will be exhibiting at the 2014 Arab Health Congress in Dubai, UAE, held January 27 th -30 th , at the Dubai International Convention and Exhibition Centre. “We are proud to be involved as an exhibitor at Arab Health” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.

ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain Clinical Laboratory licensure and accreditations, such as ISO15189, College of American Pathologists (CAP) accreditation and US International CLIA certification. “Internationally recognized clinical laboratory accreditations provide our clients with a competitive edge. These accreditations and licensures have enabled

our clients to successfully compete for multi-national based clinical trial studies and demonstrate the internationally recognized quality of their laboratories” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx

“In addition, as the leading Contract Diagnostics Organization, ResearchDx can provide strategic partnerships to Middle Eastern biopharmaceutical and diagnostic companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services” said Dr. Mathew Moore.

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and clinical laboratory consulting. Additional information is available at www.researchdx.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .

" title="http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140126005022r1&sid=16929&distro=ftp\"/>" target="_blank" rel="nofollow">cts.businesswire.com/ct/CT?id=bwnews&sty=20140126005022r1&am ..

Philip D. Cotter, PhD, FACMG, FFSc(RCPA)ResearchDx5 Mason,

Suite 100Irvine, CA 92618 pcotter@researchdx.com : mailto:pcotter@researchdx.com 866-225-9195
/ 510-332-0477


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2014 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com